General consultation on clinical breakpoints for Vibrio species 1 October - 15 November. Use the form available on the consultation webpage to comment. Queries can be addressed to gunnar.kahlmeter@eucast.org.
Get to know moreWe are frequently asked questions regarding (1) EUCAST Warning No. 7 : is this warning specifically directed at benzylpenicillin gradient tests (Etest TM , bioMérieux, and MTS TM , Liofilchem) when used for Streptococcus pneumoniae or does it apply to other bacteria, (2) is it still valid or have we…
Get to know moreCompanies are requested to complete a "company rationale document" to aid the EUCAST process of setting breakpoints for new agents. A template has been available for many years. It is now revised .
Get to know morePublication in Journal of Antimicrobial Chemotherapy: Vibrio species - development of EUCAST susceptibility testing methods and MIC and zone diameter distributions on which to determine clinical breakpoints . Onur Karatuna et al. December 2023.
Get to know moreThe web page " Information for industry " has been supplemented with more information; specifically on the development of disks (content) and of reference MIC and Zone diameter material for EUCAST decisions on breakpoints.
Get to know moreThe breakpoint tables have been updated from 13.0 (1 Jan, 2023) to 13.1 (29 June, 2023). This allows the AST of several additional agents for anaerobic bacteria. There is a matching update of QC tables.
Get to know moreInvestigations into the problems with susceptibility testing of species with breakpoints for cefiderocol have been performed by EUCAST and others. The warning has been updated 16 August, 2022. Work is continued and further updates may be expected.
Get to know moreThe next breakpoint table (valid from 1 Jan, 2023) is now available for comments and questions. Please address comments to erika.matuschek[at]eucast.org or gunnar.kahlmeter[at]eucast.org no later than 19 December, 2022.
Get to know moreOrganisation The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is mandated by ESCMID, EMA, ECDC, EFSA and partners across Europe to define, harmonize and standardize antimicrobial breakpoints and testing methods. EUCAST structure and procedures have been developed with ESCMID,…
Get to know moreStriving to keep EUCAST users informed of upcoming changes, this short document describes the planned major changes to the breakpoint tables v 11.0 (2021). The table itself will be published for consultation on or about 5 December, 2020.
Get to know more